i-SENS (099190) Fundamentals 2026 — Revenue Analysis | SniperIQ
i-SENS (099190) is a KR-listed Healthcare company in Medical - Specialties with a market capitalization of ₩437.4B, trading at ₩15270.00 on the KOE. This SniperIQ fundamentals page covers i-SENS's valuation, profitability (net margin -1.8%), revenue (₩315.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is i-SENS's market cap?
i-SENS (099190) has a market capitalization of approximately ₩437.4B, trading at ₩15270.00 on the KOE. Market cap moves with the live share price.
What is i-SENS's P/E ratio?
i-SENS's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is i-SENS?
i-SENS runs a net profit margin of -1.8%, a gross margin of 38.0%, and an operating margin of 1.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does i-SENS generate?
i-SENS reported revenue of ₩315.7B for fiscal year 2025, with net income of -₩5.1B and earnings per share (EPS) of -186.61. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does i-SENS pay a dividend?
i-SENS offers a trailing dividend yield of about 0.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is i-SENS financially healthy?
i-SENS carries a debt-to-equity ratio of 0.51x and a current ratio of 1.70x, with a market beta of 0.49. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is i-SENS a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For i-SENS (099190) the key facts are: market cap ₩437.4B, revenue ₩315.7B, 52-week range 14000-27600. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track i-SENS's full fundamentals live
Get i-SENS's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.